Category: Adjuvant Capital
ChromaCode’s tech to boost COVID-19 testing gets Bill Gates backing
Boasting a technology that can dramatically increase the capacity of existing polymerase chain reaction (PCR) testing used to identify people infected with COVID-19 and other illnesses, ChromaCode has attracted new funding from Bill Gates-backed Adjuvant Capital. “We want a good solution for a resource-limited environment,” says ChromaCode founder and executive chairman…
Read More
African genomics startup 54gene raises $15M led by Adjuvant Capital
Greater availability of African genomic data could lead to medical breakthroughs for the continent’s 1.2 billion people. That’s the driving proposition of 54gene — a U.S. and Nigeria based startup — that collects African genetic code for use in health research and drug development. The company has closed a $15…
Read More